Results 201 to 210 of about 35,836 (258)

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts. [PDF]

JCO Precis Oncol
Carranza O, Pant S, Schuler M, Witt O, Geoerger B, Loriot Y, Farouk Sait S, Arnold D, Dal Molin GZ, Lugowska I, Winter H, Baldini C, Corassa M, Thomas S, Crow L, Xia Y, Triantos S, Sweiti H, Reardon DA.   +18 more
europepmc   +1 more source

<i>Codonopsis pilosula</i> Lipophilic Extract-Loaded Thermosensitive Nanogel Attenuates Skin Photoaging by Inhibiting the FGFR/PI3K/AKT/mTOR Pathway. [PDF]

Pharmaceutics
Zhou J, Ge Y, Li R, Cheng Z, Gao J, Zheng B.   +5 more
europepmc   +1 more source

Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids. [PDF]

Mol Ther Oncol
Birgersson M, Lukoseviciute M, Kostopoulou ON, Dalianis T.   +3 more
europepmc   +1 more source

Integrative multi-omics and single-cell analysis identifies EGFR pathway activation and metabolic reprogramming as potential synthetic lethal vulnerabilities in resistance to the FGFR inhibitor AZD4547. [PDF]

J Transl Med
Tan L, Hou T, Ying P, Wang X, Jin H, Luo J.   +5 more
europepmc   +1 more source

FGFR2 fusion-driven cholangiocarcinoma is characterized by a distinct neutrophil-enriched tumor microenvironment in a syngeneic murine model. [PDF]

JHEP Rep
Lekiashvili N, Dinh TK, Olkus A, Wu YL, Liu CS, Komkova D, Stenzinger A, Hartmann FJ, Longerich T, Dill MT.   +9 more
europepmc   +1 more source

<i>FGFR3</i> gene alteration and protein expression in upper urinary tract carcinoma: unsuitability of ureteroscopic biopsy specimens for <i>FGFR3</i> RNA testing. [PDF]

Explor Target Antitumor Ther
Miyake M, Oda Y, Nishimura N, Ohnishi S, Miyazaki K, Shimizu T, Owari T, Iida K, Fujimoto K.   +8 more
europepmc   +1 more source

FGFR inhibitor resistance in cervical cancer: a role for integrin α2 and mTOR signalling. [PDF]

Front Cell Dev Biol
Bou Antoun N, Grose RP, Walker AJ, Modjtahedi H, Chioni AM.   +4 more
europepmc   +1 more source

Modern therapeutic approaches in cholangiocarcinoma: A narrative review of key biomarkers and clinical trials. [PDF]

Transl Oncol
Almeida A, Manzi J, Hoff C, Kadri H, Livingstone A, Gleisner A, Toegel EB, Schulick R, Hoff PM, Vianna R, Abreu P.   +10 more
europepmc   +1 more source